Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


COP31 climate talks break down as EU, others reject deal
Indonesia factory fire search to resume Monday as 24 body bags recovered
Israel's Eisenkot condemns arson attacks by settlers in West Bank
At least 14 people missing after Russian drone hit building in Kyiv region
Fire breaks out at Bahrain's civilian industrial facility after Iranian attack
